USA flag logo/image

An Official Website of the United States Government

Medical Provider Training on Prescription Opioid Addiction in Pregnant Women

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R43DA035020
Solicitation Year:
2012
Solicitation Topic Code:
NIDA
Solicitation Number:
PA12-088
Small Business Information
RMC RESEARCH CORPORATION
111 SW COLUMBIA ST, STE 1200 PORTLAND, OR 97201-5843
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: Medical Provider Training on Prescription Opioid Addiction in Pregnant Women
Agency: HHS
Contract: 1R43DA035020-01
Award Amount: $149,646.00
 

Abstract:

DESCRIPTION (provided by applicant): The past decade has seen growing concern over the nonmedical use of prescription opioids and over substantial increases in public health consequences of prescription opioid misuse. Increased rates of neonatal abstinencesyndrome, a constellation of symptoms associated with opioid withdrawal among neonates, has raised awareness in the medical community of prescription opioid addiction among pregnant women. We propose to develop and evaluate an interactive self-directed e-learning course for medical personnel in identifying and responding to prescription opioid misuse and addiction among pregnant women patients toward the goal of improving neonatal and maternal outcomes. The course will adapt existing tools on screening andbrief intervention and opioid prescribing best practices to the needs of pregnant women and synthesize these tools with clinical recommendations on treatment of opioid addiction in pregnant women. The ultimate goal is a CME/CE-accredited course targetingmedical providers who care for pregnant women. The specific aims of this Phase I project are to 1) develop a curriculum plan for an elearning course for medical providers on prescription opioid addiction among pregnant women patients, 2) create a prototypemodule including a case vignette, interactive questions, and downloadable tools, and 3) evaluate provider satisfaction with and perception of the utility of the curriculum plan; and usability of the prototype module. Curriculum plan and prototype module development will be informed by expert consultation, literature review, medical provider focus groups, and review of tools in relevant areas. A team of collaborators composed of experts in the areas of pain management, behavioral and pharmacologic treatmentof substance use disorders in pregnant women, and technology transfer were chosen to contribute to the team's overall content expertise. Once the curriculum plan and prototype module are developed, medical providers from Oregon Health and Sciences University will be recruited to participate in focus groups to offer feedback on utility and usability. If Phase I establishes the feasibility of the proposed course, Phase II will provide the opportunity for completion of the course, including all modules, casevignettes, and supporting tools, concluding with a summative study assessing impact of the course on provider knowledge, skills, and self-efficacy; as well as provider satisfaction with the course. PUBLIC HEALTH RELEVANCE: Public health consequences of prescription opioid misuse increased substantially in the past decade. A rise in prescription opioid addiction among women of childbearing age is of particular concern to the medical community due to the impact on fetal and neonatal health and the public health and medical costs of treating opioid-exposed neonates. The proposed e-learning course for medical personnel is a cost-effective, scalable means of technology transfer on identifying and responding to prescription opioid misuse and addiction among pregnant women patients toward the goal of improving neonatal and maternal outcomes.

Principal Investigator:

Kelly J. Vander ley
503-223-8248
kvanderley@rmccorp.com

Business Contact:

Stephen L. Murray
503-223-8248
smurray@rmccorp.com
Small Business Information at Submission:

RMC RESEARCH CORPORATION
111 SW COLUMBIA ST, STE 1200 PORTLAND, OR 97201-5843

EIN/Tax ID: 152081907
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No